Company Filing History:
Years Active: 2020
Title: The Innovative Mind of Serguei Nabirotchkin
Introduction
Serguei Nabirotchkin is a notable inventor based in Chatenay-Malabry, France. He has made significant contributions to the field of neurological disorders through his innovative research and patent.
Latest Patents
Nabirotchkin holds a patent for "Combinatorial therapies of neurological disorders." This invention focuses on combinations and methods for treating neurological disorders related to Amyloid beta toxicity and neuronal death. Specifically, it addresses novel combinatorial therapies for conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, among others. His work emphasizes the use of 3-phenylsulfonyl-8-(piperazin-1-yl) quinoline and baclofen and/or acamprosate in these therapies. He has 1 patent to his name.
Career Highlights
Serguei Nabirotchkin is currently associated with Pharnext, a company dedicated to developing innovative treatments for neurological diseases. His work at Pharnext has positioned him as a key player in the advancement of therapies aimed at improving the lives of patients suffering from debilitating neurological conditions.
Collaborations
Nabirotchkin has collaborated with notable colleagues in his field, including Daniel Cohen and Rodolphe Hajj. These partnerships have further enhanced his research and contributed to the development of effective therapeutic strategies.
Conclusion
Serguei Nabirotchkin's innovative contributions to the treatment of neurological disorders highlight his importance in the field of medical research. His patent and ongoing work at Pharnext demonstrate his commitment to improving patient outcomes through scientific advancement.